TBK1 and neoplasm: The results showed that compared with control group and DS-8201 treatment group, phosphorylation of TBK1 in EpCAM+ xenograft tumor cells was much higher in the ADU-S100 treatment group and combined treatment group (Figure 7I, Figure S4C).